We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.
- Authors
Keller, Marla J; Burk, Robert D; Xie, Xianhong; Anastos, Kathryn; Massad, L Stewart; Minkoff, Howard; Xue, Xiaonan; D'Souza, Gypsyamber; Watts, D Heather; Levine, Alexandra M; Castle, Philip E; Colie, Christine; Palefsky, Joel M; Strickler, Howard D
- Abstract
US cervical cancer screening guidelines for human immunodeficiency virus (HIV)-uninfected women 30 years or older have recently been revised, increasing the suggested interval between Papanicolaou (Pap) tests from 3 years to 5 years among those with normal cervical cytology (Pap test) results who test negative for oncogenic human papillomavirus (HPV). Whether a 3-year or 5-year screening interval could be used in HIV-infected women who are cytologically normal and oncogenic HPV-negative is unknown.
- Publication
JAMA, 2012, Vol 308, Issue 4, p362
- ISSN
1538-3598
- Publication type
Journal Article
- DOI
10.1001/jama.2012.5664